← Back to Search
MYC-induced Apoptosis In Mammary Epithelial Cells Is Associated With Repression Of Lineage-specific Gene Signatures
Heidi M. Haikala, J. Klefström, M. Eilers, Katrin E. Wiese
Published 2016 · Biology, Medicine
Download PDFAnalyze on Scholarcy
ABSTRACT Apoptosis caused by deregulated MYC expression is a prototype example of intrinsic tumor suppression. However, it is still unclear how supraphysiological MYC expression levels engage specific sets of target genes to promote apoptosis. Recently, we demonstrated that repression of SRF target genes by MYC/MIZ1 complexes limits AKT-dependent survival signaling and contributes to apoptosis induction. Here we report that supraphysiological levels of MYC repress gene sets that include markers of basal-like breast cancer cells, but not luminal cancer cells, in a MIZ1-dependent manner. Furthermore, repressed genes are part of a conserved gene signature characterizing the basal subpopulation of both murine and human mammary gland. These repressed genes play a role in epithelium and mammary gland development and overlap with genes mediating cell adhesion and extracellular matrix organization. Strikingly, acute activation of oncogenic MYC in basal mammary epithelial cells is sufficient to induce luminal cell identity markers. We propose that supraphysiological MYC expression impacts on mammary epithelial cell identity by repressing lineage-specific target genes. Such abrupt cell identity switch could interfere with adhesion-dependent survival signaling and thus promote apoptosis in pre-malignant epithelial tissue.
This paper references
c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells
Zuqin Nie (2012)
Apoptotic signaling by c-MYC
B. Hoffman (2008)
Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity
A. Keymeulen (2015)
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
C. Lin (2012)
Generation of a functional mammary gland from a single stem cell
M. Shackleton (2006)
Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice
R. Jäger (1997)
PIK3CAH1047R induces multipotency and multi-lineage mammary tumours
S. Koren (2015)
BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells.
G. Molyneux (2010)
c - Myc Is a Universal Ampli fi er of Expressed Genes in Lymphocytes and Embryonic Stem
S Walz (2012)
The ConsensusPathDB interaction database: 2013 update
A. Kamburov (2013)
c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny
I. Arnold (2001)
Key signalling nodes in mammary gland development and cancer: Myc
N. Hynes (2009)
Repression of SRF target genes is critical for Myc‐dependent apoptosis of epithelial cells
Katrin E Wiese (2015)
Functional analysis of the N-terminal domain of the Myc oncoprotein
S. K. Oster (2003)
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
C. Eischen (1999)
Bim is a suppressor of Myc-induced mouse B cell leukemia.
A. Egle (2004)
with elevated c - Myc
Z Nie (2012)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.
R. Neve (2006)
ConsensusPathDB: toward a more complete picture of cell biology
A. Kamburov (2011)
Induction of Cell Cycle Progression and Acceleration of Apoptosis Are Two Separable Functions of c-Myc: Transrepression Correlates with Acceleration of Apoptosis
S. Conzen (2000)
Differential regulation of cell cycle characteristics and apoptosis in MMTV-myc and MMTV-ras mouse mammary tumors.
J. E. Hundley (1997)
Induction of apoptosis in fibroblasts by c-myc protein
G. Evan (1992)
Transcriptional ampli fi cation in tumor
Suppression of Myc-Induced Apoptosis in β Cells Exposes Multiple Oncogenic Properties of Myc and Triggers Carcinogenic Progression
S. Pelengaris (2002)
Modelling glandular epithelial cancers in three-dimensional cultures
J. Debnath (2005)
angesichts der Corona-Pandemie (1998)
Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice.
E. Sandgren (1995)
MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition
D. Horiuchi (2012)
MYC in mammalian epidermis: how can an oncogene stimulate differentiation?
F. Watt (2008)
Subtypes of breast cancer show preferential site of relapse.
M. Smid (2008)
Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis
A. Sabò (2014)
Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways
E. Lim (2010)
Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization
Johanna I. Partanen (2007)
Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.
C. Escot (1986)
Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.
D. Askew (1991)
Gene expression profiling of breast cell lines identifies potential new basal markers
E. Charafe-Jauffret (2006)
MYC on the Path to Cancer
C. Dang (2012)
A MYC-Driven Change in Mitochondrial Dynamics Limits YAP/TAZ Function in Mammary Epithelial Cells and Breast Cancer.
B. von Eyss (2015)
Differential effects on ARF stability by normal versus oncogenic levels of c-Myc expression.
D. Chen (2013)
Myc regulates keratinocyte adhesion and differentiation via complex formation with Miz1
A. Gebhardt (2006)
Bim is a suppressor of Mycinduced mouse B cell leukemia
A Egle (2004)
Revisiting Global Gene Expression Analysis
J. Lovén (2012)
Evidence that Myc activation depletes the epidermal stem cell compartment by modulating adhesive interactions with the local microenvironment
M. Frye (2003)
Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes
T. Stewart (1984)
Distinct thresholds govern Myc's biological output in vivo.
D. J. Murphy (2008)
c-Myc affects mRNA translation, cell proliferation and progenitor cell function in the mammary gland
Tina Stoelzle (2009)
Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.
J. Debnath (2003)
Isogenic normal basal and luminal mammary epithelial isolated by a novel method show a differential response to ionizing radiation.
G. Huper (2007)
Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate
H. Kendrick (2008)
Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation
Marie-Liesse Asselin-Labat (2007)
Targeted c‐myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcription.
C. A. Schoenenberger (1988)
PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells.
G. Buchwalter (2013)
Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles
S. Walz (2014)
Deregulated expression of c-Myc depletes epidermal stem cells
R. Waikel (2001)
This paper is referenced by
Increased expression of Myc-interacting zinc finger protein 1 in APP/PS1 mice
L. Liu (2017)
Abstract. Myc-interacting zinc-finger protein 1 (Miz1) is a member of the poxvirus and zinc-finger domain/zinc finger transcription factor family. Its transcription activation and repression functions in the nucleus are well elucidated;
Lu Liu (2017)
Proteomic Analysis of Breast Cancer Resistance to the Anticancer Drug RH1 Reveals the Importance of Cancer Stem Cells
Dalius Kučiauskas (2019)